SEC 13F Intelligence

Foresite Capital Management Vi LLC / DNLI

Foresite Capital Management Vi LLC’s Denali Therapeutics Inc Position

Does Foresite Capital Management Vi LLC own Denali Therapeutics Inc (DNLI)? Yes — 1.21M shares worth $23M (+5.05% of its 13F portfolio) as of Q1 2026, up from 1.00M shares the prior filed quarter.

Position Value
$23M
Q1 2026
Shares
1.21M
% of Portfolio
+5.05%
Quarters Held
3
currently held

Position History DNLI

Reported value by quarter
Q3 ’25: $15MQ3 ’25Q4 ’25: $17MQ4 ’25Q1 ’26: $23MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.21M$23M+5.05%
Q4 20251.00M$17M+4.99%
Q3 20251.00M$15M+5.61%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Foresite Capital Management Vi LLC’s full portfolio or all institutional holders of DNLI.